Sökning: WFRF:(Selke Gisbert) >
Utilisation Trend o...
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe : Findings and Implications
-
- Godman, Brian (författare)
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK;Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa;School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
-
- Wladysiuk, Magdalene (författare)
- Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland;HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland
-
- McTaggart, Stuart (författare)
- Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK
-
visa fler...
-
- Kurdi, Amanj (författare)
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK;Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa;Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq
-
- Allocati, Eleonora (författare)
- Istituto di Ricerche Farmacologiche ‘Mario Negri’ IRCCS, Milan, Italy
-
- Jakovljevic, Mihajlo (författare)
- Department of Global Health Economics and Policy, University of Kragujevac, Kragujevac, Serbia;Institute of Comparative Economic Studies, Faculty of Economics, Hosei University Tokyo, Tokyo, Japan
-
- Kalemeera, Francis (författare)
- Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia
-
- Hoxha, Iris (författare)
- Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania
-
- Nachtnebel, Anna (författare)
- Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
-
- Sauermann, Robert (författare)
- Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
-
- Hinteregger, Manfred (författare)
- Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
-
- Marković-Peković, Vanda (författare)
- Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
-
- Tubic, Biljana (författare)
- Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina;Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina
-
- Petrova, Guenka (författare)
- Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria
-
- Tachkov, Konstantin (författare)
- Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria
-
- Slabý, Juraj (författare)
- State Institute for Drug Control, Prague, Czech Republic
-
- Nejezchlebova, Radka (författare)
- State Institute for Drug Control, Prague, Czech Republic
-
- Krulichová, Iva Selke (författare)
- Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic
-
- Laius, Ott (författare)
- State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia
-
- Selke, Gisbert (författare)
- Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany
-
- Langner, Irene (författare)
- Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany
-
- Harsanyi, András (författare)
- Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary
-
- Inotai, András (författare)
- Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary
-
- Jakupi, Arianit (författare)
- Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo
-
- Henkuzens, Svens (författare)
- Independent Consultant, Riga, Latvia
-
- Garuolienė, Kristina (författare)
- Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
-
- Gulbinovič, Jolanta (författare)
- Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
-
- Bonanno, Patricia Vella (författare)
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK;Department of Health Services Management, University of Malta, Valletta, Malta
-
- Rutkowski, Jakub (författare)
- HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland
-
- Ingeberg, Skule (författare)
- Medicines Committee, Oslo University Hospitals, Oslo, Norway
-
- Melien, Øyvind (författare)
- Medicines Committee, Oslo University Hospitals, Oslo, Norway
-
- Mardare, Ileana (författare)
- Faculty of Medicine, Public Health and Management Department, “Carol Davila” University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania
-
- Fürst, Jurij (författare)
- Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia
-
- MacBride-Stewart, Sean (författare)
- Pharmacy Services, Greater Glasgow and Clyde (NHS GGC), Glasgow, UK
-
- Holmes, Carol (författare)
- NHS Lothian, Edinburgh, UK
-
- Pontes, Caridad (författare)
- Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain;Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain
-
- Zara, Corinne (författare)
- Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain
-
- Pedrola, Marta Turu (författare)
- Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain
-
- Hoffmann, Mikael (författare)
- NEPI-Nätverk för läkemedelsepidemiologi, Stockholm, Sweden
-
- Kourafalos, Vasileios (författare)
- National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece
-
- Pisana, Alice (författare)
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
-
- Banzi, Rita (författare)
- Istituto di Ricerche Farmacologiche ‘Mario Negri’ IRCCS, Milan, Italy
-
- Campbell, Stephen (författare)
- Centre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK;NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK
-
- Wettermark, Björn (författare)
- Uppsala universitet,Institutionen för farmaci,Pharmacoepidemiology
-
Melien, O (författare)
-
visa färre...
-
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK;Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa;School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland;HTA Consulting, Starowiślna Str 17/3, 31-038 Krakow, Poland (creator_code:org_t)
- Hindawi Publishing Corporation, 2021
- 2021
- Engelska.
-
Ingår i: BioMed Research International. - : Hindawi Publishing Corporation. - 2314-6133 .- 2314-6141. ; 2021
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://downloads.hi...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background. Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed to reduce hypoglycaemia and improve patient convenience. There are concerns though with their considerably higher costs, but moderated by reductions in complications and associated costs. Biosimilars can help further reduce costs. However, to date, price reductions for biosimilar insulin glargine appear limited. In addition, the originator company has switched promotional efforts to more concentrated patented formulations to reduce the impact of biosimilars. There are also concerns with different devices between the manufacturers. As a result, there is a need to assess current utilisation rates for insulins, especially long-acting insulin analogues and biosimilars, and the rationale for patterns seen, among multiple European countries to provide future direction.Methodology. Health authority databases are examined to assess utilisation and expenditure patterns for insulins, including biosimilar insulin glargine. Explanations for patterns seen were provided by senior-level personnel.Results. Typically increasing use of long-acting insulin analogues across Europe including both Western and Central and Eastern European countries reflects perceived patient benefits despite higher prices. However, activities by the originator company to switch patients to more concentrated insulin glargine coupled with lowering prices towards biosimilars have limited biosimilar uptake, with biosimilars not currently launched in a minority of European countries. A number of activities were identified to address this. Enhancing the attractiveness of the biosimilar insulin market is essential to encourage other biosimilar manufacturers to enter the market as more long-acting insulin analogues lose their patents to benefit all key stakeholder groups.Conclusions. There are concerns with the availability and use of insulin glargine biosimilars among European countries despite lower costs. This can be addressed.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)
Nyckelord
- General Immunology and Microbiology
- General Biochemistry
- Genetics and Molecular Biology
- General Medicine
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Godman, Brian
-
Wladysiuk, Magda ...
-
McTaggart, Stuar ...
-
Kurdi, Amanj
-
Allocati, Eleono ...
-
Jakovljevic, Mih ...
-
visa fler...
-
Kalemeera, Franc ...
-
Hoxha, Iris
-
Nachtnebel, Anna
-
Sauermann, Rober ...
-
Hinteregger, Man ...
-
Marković-Peković ...
-
Tubic, Biljana
-
Petrova, Guenka
-
Tachkov, Konstan ...
-
Slabý, Juraj
-
Nejezchlebova, R ...
-
Krulichová, Iva ...
-
Laius, Ott
-
Selke, Gisbert
-
Langner, Irene
-
Harsanyi, András
-
Inotai, András
-
Jakupi, Arianit
-
Henkuzens, Svens
-
Garuolienė, Kris ...
-
Gulbinovič, Jola ...
-
Bonanno, Patrici ...
-
Rutkowski, Jakub
-
Ingeberg, Skule
-
Melien, Øyvind
-
Mardare, Ileana
-
Fürst, Jurij
-
MacBride-Stewart ...
-
Holmes, Carol
-
Pontes, Caridad
-
Zara, Corinne
-
Pedrola, Marta T ...
-
Hoffmann, Mikael
-
Kourafalos, Vasi ...
-
Pisana, Alice
-
Banzi, Rita
-
Campbell, Stephe ...
-
Wettermark, Björ ...
-
Melien, O
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Hälso och sjukvå ...
- Artiklar i publikationen
-
BioMed Research ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet